All 41 tumor samples and 4 control brain samples were subjected to histological as well as molecular genetic diagnostics, and mutations at C228 and C250 of the TERT promoter region were subsequently examined for every case by Sanger sequencing, successfully detecting these two reported hotspot mutations (Figure 1(b)). This evidence concerns the gene TERT and neoplasm.